PowerPoint Presentation Peginterferon alfa-2b + RBV vs. Peginterferon alfa-2a + RBV IDEAL STUDY Phase 3 Treatment Naïve, Chronic HCV McHutchison JG, et. al. N Engl J Med.…
PowerPoint Presentation Ledipasvir-Sofosbuvir +/- 3rd DAA in HCV Genotype 1 NIH SYNERGY Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics) Kohli…
PowerPoint Presentation Peginterferon alfa-2b + RBV vs. Peginterferon alfa-2a + RBV IDEAL STUDY Phase 3, Treatment Naïve Treatment Naïve, Chronic HCV McHutchison JG,…